ÌÇÐÄvlog

Object moved to here.

Practical Guide to Recruitment of Participants for Surgical Clinical Trials | Research, Methods, Statistics | JAMA Surgery | ÌÇÐÄvlog

ÌÇÐÄvlog

[Skip to Navigation]
Sign In
1.
Emerson  MA, Reeder-Hayes  KE, Tipaldos  HJ,  et al.  Integrating biology and access to care in addressing breast cancer disparities: 25 years’ research experience in the Carolina Breast Cancer Study.   Curr Breast Cancer Rep. 2020;12(3):149-160. doi:
2.
Newman  LA, Lee  CT, Parekh  LP,  et al; American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.  Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee.  Ìý°ä²¹²Ô³¦±ð°ù. 2006;106(1):188-195. doi:
3.
Sineshaw  HM, Gaudet  M, Ward  EM,  et al.  Association of race/ethnicity, socioeconomic status, and breast cancer subtypes in the National Cancer Data Base (2010-2011).   Breast Cancer Res Treat. 2014;145(3):753-763. doi:
4.
Magnuson  A, Bruinooge  SS, Singh  H,  et al.  Modernizing Clinical Trial Eligibility Criteria: recommendations of the ASCO-Friends of Cancer Research Performance Status Work Group.   Clin Cancer Res. 2021;27(9):2424-2429. doi:
5.
US Department of Health & Human Services. Additional protections for pregnant women, human fetuses and neonates involved in research. Accessed February 1, 2022.
6.
Reaman  GH.  Pediatric cancer research from past successes through collaboration to future transdisciplinary research.   J Pediatr Oncol Nurs. 2004;21(3):123-127. doi:
7.
Eggly  S, Barton  E, Winckles  A, Penner  LA, Albrecht  TL.  A disparity of words: racial differences in oncologist-patient communication about clinical trials.   Health Expect. 2015;18(5):1316-1326. doi:
Guide to Statistics and Methods
Randomized Clinical Trials in Surgery
October 26, 2022

Practical Guide to Recruitment of Participants for Surgical Clinical Trials

Author Affiliations
  • 1Department of Surgery, Weill Cornell Medicine, New York, New York
  • 2Department of Biostatistics, University of North Carolina at Chapel Hill
  • 3Statistical Editor, JAMA Surgery
  • 4Department of Surgery, Amsterdam University Medical Center, Academic Medical Center, University of Amsterdam, Amsterdam, the Netherlands
JAMA Surg. 2022;157(12):1156-1157. doi:10.1001/jamasurg.2022.4886

Prospective randomized clinical trials are considered to produce the highest-level evidence regarding intervention benefits for the health and well-being of the study population. Patient participation requires confidence and trust.

We live in a diverse society, characterized by a spectrum of genetic, lifestyle, and socioeconomic features that can influence efficacy of a drug or intervention. Research results cannot be generalized unless trial participants reflect the diversity of the large-scale community. An important first step in ensuring such representation involves having a clinical trial research team that is diverse and cognizant of overall population heterogeneity. Relevant research questions must be aligned with appropriate statistical plans.

×